BRIEF published on 07/11/2024 at 13:05, 1 year 9 months ago CureVac met à jour les dates des procès pour les litiges en matière de brevets contre Pfizer/BioNTech CureVac Contentieux Des Brevets Pfizer/BioNTech Dates Du Procès Mise À Jour Juridique
PRESS RELEASE published on 07/11/2024 at 13:00, 1 year 9 months ago CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech CureVac provides trial date updates for patent litigation against Pfizer/BioNTech in multiple geographies, including the U.S., UK, and Germany BioNTech CureVac Patent Litigation Pfizer Trial Dates
BRIEF published on 07/03/2024 at 08:17, 1 year 10 months ago CureVac Announces Strategic Restructuring to Focus on High-Value mRNA Opportunities Licensing Agreement MRNA Technology Oncology Research Strategic Restructuring Workforce Reduction
BRIEF published on 07/03/2024 at 08:17, 1 year 10 months ago CureVac annonce une restructuration stratégique pour se concentrer sur les opportunités d'ARNm de grande valeur Recherche En Oncologie Technologie ARNm Restructuration Stratégique Réduction Des Effectifs Contrat De Licence
BRIEF published on 07/03/2024 at 08:14, 1 year 10 months ago GSK and CureVac to Restructure Collaboration into New Licensing Agreement Licensing Agreement GSK CureVac MRNA Vaccines
BRIEF published on 07/03/2024 at 08:14, 1 year 10 months ago GSK et CureVac vont restructurer leur collaboration dans le cadre d'un nouvel accord de licence GSK CureVac Vaccins Contrat De Licence ARNm
PRESS RELEASE published on 07/03/2024 at 08:12, 1 year 10 months ago CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities CureVac initiates strategic restructuring to focus on high-value mRNA pipeline opportunities, including workforce reduction and new GSK agreement Oncology Strategic Restructuring CureVac MRNA Pipeline GSK Agreement
PRESS RELEASE published on 07/03/2024 at 08:09, 1 year 10 months ago GSK and CureVac to Restructure Collaboration into New Licensing Agreement GSK and CureVac restructure collaboration into new licensing agreement for mRNA vaccines development, manufacturing, and commercialization globally Licensing Agreement Collaboration GSK MRNA Vaccines CureVac
BRIEF published on 06/24/2024 at 22:10, 1 year 10 months ago CureVac Announces Voting Results of General Meeting Annual General Meeting Voting Results Board Appointments CureVac MRNA
BRIEF published on 06/24/2024 at 22:10, 1 year 10 months ago CureVac annonce les résultats du vote de l'assemblée générale Assemblée Générale Annuelle Nominations Au Conseil CureVac Résultats Du Vote ARNm
Published on 05/07/2026 at 16:35, 23 minutes ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 1 hour 43 minutes ago ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 14:35, 2 hours 23 minutes ago Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 2 hours 28 minutes ago Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 14:30, 2 hours 28 minutes ago Loar Holdings Inc. Reports Q1 2026 Record Results and Upward Revision to 2026 Outlook
Published on 05/07/2026 at 16:25, 33 minutes ago VARON Reinforces Commitment to Seasonal Respiratory Wellness During Allergy Season Across Europe
Published on 05/07/2026 at 16:25, 33 minutes ago Medit Establishes Global Orthodontic Business Division, Anchored by Strategic Acquisition of Progressive Orthodontics
Published on 05/07/2026 at 16:15, 43 minutes ago 157th Annual General Meeting at wienerberger: All Resolutions Adopted
Published on 05/07/2026 at 15:55, 1 hour 3 minutes ago MENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD
Published on 05/07/2026 at 15:28, 1 hour 30 minutes ago JOST’s Annual General Meeting approves dividend of EUR 1.50 per share and elects new Supervisory Board member
Published on 05/07/2026 at 15:00, 1 hour 58 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 05/07/2026 at 07:43, 9 hours 15 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 22 hours 58 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 22 hours 58 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
